Шрифт:
Snyder, S. H. Drugs and the Brain.New York: Scientific American Books, 1986.
Tsvetkov, E., W. A. Carlezon Jr., F. M. Benes, E. R. Kandel & V. Y. Bolshakov. Fear conditioning occludes LTP-induced presynap-tic enhancement of synaptic transmission in the cortical pathway to the lateral amygdala.Neuron 34 (2002): 289–300.
26. Новый способ лечения психических заболеваний
Сведения, приведенные в этой главе, почерпнуты из следующих источников:
Abi-Dargham, A., D. R. Hwang, У. Huang, Y. Zea-Ponce, D. Martinez, I. Lombardo, A. Broft, T. Hashimoto, M. Slifstein, O. Mawlawi, R. VanHeertum & M. Laruelle. Quantitative analysis of striatal and extrastriatal D2 receptors in humans with [18F] fallypride: Validation and reproducibility. In preparation.
Ansorge, M. S., M. Zhou, A. Lira, R. Hen & J. A. Gingrich. Early-life blockade of the 5 — HT transporter alters emotional behavior in adult mice.Science 306 (2004): 879–881.
Baddeley, A. D. Working Memory.Oxford: Clarendon Press, 1986.
Carlsson, M. L., A. Carlsson 81 M. Nilsson. Schizophrenia: From dopamine to glutamate and back.Curr. Med. Chem. 11, no. 3 (2004): 267–277.
Fuster, J. M. The prefrontal cortex — an update: Time is of the essence.Neuron 30, no. 2 (2001): 319–333.
Goldman-Rakic, P. The‘ psychic’ neuron of the cerebral cortex.An n. N. У. Acad. Sci. 868 (1999): 13–26.
Huang, Y. Y., E. Simpson, C. Kellendonk 81 E. R. Kandel. Genetic evidence for the bi-directional modulation of synaptic plasticity in the prefrontal cortex by Di receptors.Proc. Nad. Acad. Sci. USA 101 (2004): 3236–3241.
Jacobsen, C. F. Studies of Cerebral Function in Primates.Baltimore: Johns Hopkins University Press, 1936.
Kandel, E. R. Disorders of thought: Schizophrenia.In: Principles of Neural Science. 3rd ed. Ed. E. R. Kandel, J. H. Schwartz & Т. M. jessell, 853–868. New York: Elsevier, 1991.
Lawford, B. R., R. M. Young, E. P. Noble, B. Kann, L. Arnold, J. Rowell 81 T. L. Ritchie. D2 dopamine receptor gene polymorphism: Paroxetine and social functioning in posttraumatic stress disorder.Euro. Neuropsychopharm. 13, no. 5 (2003): 313–320.
Santarelli, L., M. Saxe, C. Gross, A. Surget, F. Battaglia, S. Dulawa, N. Weisstaub, J. Lee, R. Duman, 0. Arancio, C. Belzung 81 R. Hen. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants.Science 301 (2003): 805–809.
Seeman, P., T. Lee, M. Chau-Wong & K. Wong. Antipsychotic drug doses and neuroleptic/dopamine receptors.Nature 261 (1976): 717–719.
Snyder, S. H. Drugs and the Brain.New York: Scientific American Books, 1986.
Schwartz, J. М., P. W. Stoessel, L. R. Baxter, К. M. Martin & М. E. Phelps. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorders.Arch. Gen. Psychiatry 53 (1996): 109–113.
27. Биология и возрождение психоанализа
Об основах психоанализа см.: С. Brenner, An Elementary Textbook of Psychoanalysis,rev. ed. (New York: International University Press, 1973). О работах Аарона Бека см.: J. S. Beck, Cognitive Therapy: Basics and Beyond(New York: Guilford, 1995).
Один из примеров конструктивной критики эмпирически проверенных методов психотерапии: D. Westen, С. М. Novotny & Н. Thompson Brenner, The empirical status of empirically supported psychotherapies: Assumptions, findings, and reporting in controlled clinical trials,Psychol. Bull. 130 (2004): 631–663.
Другие сведения, приведенные в этой главе, почерпнуты из следующих источников:
Etkin, А., К. С. Klemenhagen, J. T. Dudman, М. Т. Rogan, R. Hen, E. R. Kandel &J. Hirsch. Individual differences in trait anxiety predict the response of the basolateral amygdala to unconsciously processed fearful faces.Neuron 44 (2004): 1043–1055.
Etkin, A., C. Pittenger, H. J. Polan &.E. R. Kandel. Towards a neurobiology of psychotherapy: Basic science and clinical applications.J. Neuropsychiatry Clin. Neurosci. 17 (2005): 145–158.